A step forward in the evidence-based treatment of opportunist mycobacteria.
Ormerod
P
P
D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D004977:Ethambutol / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D006801:Humans; D009164:Mycobacterium Infections / Q000150:complications / Q000188:drug therapy*; D009894:Opportunistic Infections / Q000150:complications / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D012293:Rifampin / Q000627:therapeutic use; D006113:United Kingdom
D000904:Antibiotics, Antitubercular; D004977:Ethambutol; D012293:Rifampin